1858B |
Drugs of Abuse (10 Panel) and Alcohol Screen, Blood |
1858SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
1858U |
Drugs of Abuse (9 Panel) and Alcohol Screen, Urine |
1864B |
Drugs of Abuse Screen (11 Panel), Blood |
1864ME |
Drugs of Abuse Screen (10 Panel), Meconium |
1864SP |
Drugs of Abuse Screen (11 Panel), Serum/Plasma |
1864U |
Drugs of Abuse Screen (10 Panel), Urine |
2540B |
LSD Trace Analysis, Blood |
2540SP |
LSD Trace Analysis, Serum/Plasma |
2540U |
LSD Trace Analysis, Urine |
2541B |
LSD Screen, Blood |
2541SP |
LSD Screen, Serum/Plasma |
2541U |
LSD Screen, Urine |
2679B |
Mescaline, Blood |
2679SP |
Mescaline, Serum/Plasma |
2679U |
Mescaline, Urine |
2680B |
Mescaline Screen, Blood |
2680SP |
Mescaline Screen, Serum/Plasma |
2680U |
Mescaline Screen, Urine |
3532B |
IT Testing |
3532SP |
Phencyclidine Screen, Serum/Plasma |
3532U |
Phencyclidine Screen, Urine |
3957SP |
Procyclidine, Serum/Plasma |
5417B |
Mescaline Confirmation (Qualitative), Blood |
5417SP |
Mescaline Confirmation (Qualitative), Serum/Plasma |
5417U |
Mescaline Confirmation (Qualitative), Urine |
5657B |
Phencyclidine Confirmation, Blood |
5657FL |
Phencyclidine Confirmation, Fluid |
5657ME |
Phencyclidine Confirmation (Qualitative), Meconium |
5657SP |
Phencyclidine Confirmation, Serum/Plasma |
5657TI |
Phencyclidine Confirmation, Tissue |
5657U |
Phencyclidine Confirmation, Urine |
5704ME |
Phencyclidine Confirmation (Qualitative), Meconium |
5811B |
LSD Confirmation, Blood |
5811SP |
LSD Confirmation, Serum/Plasma |
5811U |
LSD Confirmation, Urine |
5902H |
Phencyclidine Confirmation (Qualitative), Hair |
6904ME |
Drugs of Abuse Screen (7 Panel), Meconium |
6925H |
Phencyclidine Screen, Hair |
6943H |
Drugs of Abuse Screen (6 Panel), Hair |
6945H |
Therapeutic and Drugs of Abuse Screen, Hair |
6946H |
Drugs of Abuse Screen (9 Panel), Hair |
8052B |
Postmortem, Expanded, Blood (Forensic) |
8052FL |
Postmortem, Expanded, Fluid (Forensic) |
8052SP |
Postmortem, Expanded, Serum/Plasma (Forensic) |
8052TI |
Postmortem, Expanded, Tissue (Forensic) |
8052U |
Postmortem, Expanded, Urine (Forensic) |
8092B |
Postmortem, Prescription Drugs Screen, Blood (Forensic) |
8092FL |
Postmortem, Prescription Drugs Screen, Fluid (Forensic) |
8092SP |
Postmortem, Prescription Drugs Screen, Serum/Plasma (Forensic) |
8092TI |
Postmortem, Prescription Drugs Screen, Tissue (Forensic) |
8092U |
Postmortem, Prescription Drugs Screen, Urine (Forensic) |
8101B |
Drugs of Abuse (10 Panel) and Alcohol Screen, Blood |
8101FL |
Drugs of Abuse (10 Panel) and Alcohol Screen, Fluid |
8101SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
8101U |
Drugs of Abuse (11 Panel) and Alcohol Screen, Urine |
8104B |
Postmortem, Fire Death Screen, Blood (Forensic) |
8758SP |
Hallucinogens Screen, Serum/Plasma |
8761B |
Phencyclidine, Blood |
8761SP |
Phencyclidine, Serum/Plasma |
8761U |
Phencyclidine, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |